Signaling Pathways - KDR - Histone Acetyltransferases (HATs) - Insulin and Insulin-like Receptors - Deubiquitinating enzymes (DUBs)
清除全部
- B5873 Spautin-11 CitationTarget: Deubiquitinating enzymes (DUBs)|AutophagySummary: 自噬抑制剂
- B3709 Midostaurin (PKC412)中文名: 米哚妥林Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinBSummary: PKC抑制剂
- B1317 ML-323Target: Deubiquitinating enzymes (DUBs)Summary: USP1-UAF1抑制剂
- B1404 DCC-2036 (Rebastinib)Target: FLT3|Bcr-Abl|Tie-2|KDRSummary: Bcr-Abl抑制剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A8212 PR-619Target: Deubiquitinating enzymes (DUBs)Summary: 去泛素化酶(DUBs)抑制剂
- A4453 NSC 687852 (b-AP15)Target: Deubiquitinating enzymes (DUBs)Summary: 19S调节颗粒抑制剂
- A4492 NU 9056Target: Histone Acetyltransferases (HATs)Summary: KAT5(Tip60)HAT抑制剂